Article

State of Science Summit- Lung Cancer: Chaired by Missak Haigentz, MD Salma Jabbour, MD

State of Science Summit- Lung Cancer: Chaired by Missak Haigentz, MD Salma Jabbour, MD

State of Science Summit- Lung Cancer: Chaired by Missak Haigentz, MD Salma Jabbour, MD

Speakers

  • Salma Jabbour, MD | RWJ Barnabas Health and Rutgers Cancer Institute of New Jersey
  • Eshan Patel, MD | RWJ Barnabas Health and Rutgers Cancer Institute of New Jersey
  • Missak Haigentz, MD | RWJ Barnabas Health and Rutgers Cancer Institute of New Jersey
  • Malini Patel, MD | RWJ Barnabas Health and Rutgers Cancer Institute of New Jersey
  • Christian Hinrichs, MD | RWJ Barnabas Health and Rutgers Cancer Institute of New Jersey

Topics

  • Updates of ChemolO Combinations in NSCLS (in palliative and now curative intent settings)
  • Exon-20 and EGFR in NSCLC
  • Current and Emerging Targeted Therapies in NSCLC
  • SCLC Management
  • Novel Immunotherapy Approaches for Advanced Lung Cancer

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Marina Chiara Garassino, MD
Nicolas Girard, MD
Benjamin Besse, MD, PhD, director, clinical research, Gustave Roussy Institute; professor, medical oncology, Paris-Saclay University
Nicolas Girard, MD
Shirish M. Gadgeel, MD
Jacob Sands, MD
Real world evidence of treatment practices and therapeutic outcomes for newly diagnosed NSCLC patients with non-classical EGFR mutations demonstrates high unmet medical need
Phase 1 trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patients with DLL3 Positive Tumors: Patients with LCNEC
Charu Aggarwal, MD, MPH, FASCO
Andrea Wolf, MD, MPH